Literature DB >> 23652778

Low-dose furosemide administered with adequate hydration reduces contrast-induced nephropathy in patients undergoing coronary angiography.

Guo-Qiang Gu1, Rui Lu, Wei Cui, Fan Liu, Ying Zhang, Xiao-Hong Yang, Xue-Feng Chen, Wan-Ming Jia.   

Abstract

OBJECTIVE: We investigated the effects of low-dose furosemide, administered with adequate hydration on contrast-induced nephropathy (CIN).
METHODS: A total of 859 patients scheduled to undergo coronary angiography or angioplasty were enrolled and randomly assigned to a furosemide treatment or control group. All patients received supplemental hydration. Immediately after surgery, patients in the furosemide group received intravenous furosemide injection (20 mg); those in the control group received no treatment. Total fluid intake and urine output were recorded. Pre- and postsurgical changes in serum creatinine levels (SCr), glomerular filtration rate (GFR) and creatinine clearance rate (CCr) were assessed, and the incidence of CIN was also evaluated between the two groups. Logistic regression analysis was used to study risk factors for CIN.
RESULTS: General baseline conditions were similar between the two groups. Patients who received furosemide had significantly less increase in SCr and a more marked increase in GFR and CCr than those who did not. The incidence of CIN was significantly higher in the control group. Logistic regression analysis revealed that female gender and angiotensin-converting enzyme inhibitor were risk factors for CIN, whereas furosemide acted as a protective agent.
CONCLUSIONS: With full hydration, small doses of furosemide can reduce CIN better than hydration alone.
Copyright © 2013 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23652778     DOI: 10.1159/000350648

Source DB:  PubMed          Journal:  Cardiology        ISSN: 0008-6312            Impact factor:   1.869


  10 in total

1.  Additional furosemide treatment beyond saline hydration for the prevention of contrast-induced nephropathy: a meta-analysis of randomized controlled trials.

Authors:  Guoqiang Gu; Ying Zhang; Rui Lu; Wei Cui
Journal:  Int J Clin Exp Med       Date:  2015-01-15

2.  Inverse correlation between left ventricular end-diastolic pressure and contrast-induced nephropathy in patients undergoing percutaneous coronary intervention.

Authors:  Guoqiang Gu; Hanghang Xing; Yaqing Zhou; Wei Cui
Journal:  Clin Exp Nephrol       Date:  2017-12-01       Impact factor: 2.801

3.  Furosemide with saline hydration for prevention of contrast-induced nephropathy in patients undergoing coronary angiography: a meta-analysis of randomized controlled trials.

Authors:  Nana Duan; Jiegang Zhao; Zhuanzhen Li; Pingshuan Dong; Shaoxin Wang; Yuwei Zhao; Liping Wang; Hongyun Wang
Journal:  Med Sci Monit       Date:  2015-01-23

4.  Intensity of hydration changes the role of renin-angiotensin-aldosterone system blockers in contrast-induced nephropathy risk after coronary catheterisation in patients with chronic kidney disease.

Authors:  Xiao-Sheng Guo; Deng-Xuan Wu; Wei-Jie Bei; Hua-Long Li; Kun Wang; Ying-Ling Zhou; Chong-Yang Duan; Shi-Qun Chen; Dan Lian; Li-Wen Li; Yong Liu; Ning Tan; Ji-Yan Chen
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2017 Apr-Jun       Impact factor: 1.636

5.  Intermittent furosemide administration in patients with or at risk for acute kidney injury: Meta-analysis of randomized trials.

Authors:  Tiziana Bove; Alessandro Belletti; Alessandro Putzu; Simone Pappacena; Giuseppe Denaro; Giovanni Landoni; Sean M Bagshaw; Alberto Zangrillo
Journal:  PLoS One       Date:  2018-04-24       Impact factor: 3.240

6.  Effectiveness of contrast-associated acute kidney injury prevention methods; a systematic review and network meta-analysis.

Authors:  Khalid Ahmed; Terri McVeigh; Raminta Cerneviciute; Sara Mohamed; Mohammad Tubassam; Mohammad Karim; Stewart Walsh
Journal:  BMC Nephrol       Date:  2018-11-13       Impact factor: 2.388

7.  Elevated high-sensitivity C-reactive protein combined with procalcitonin predicts high risk of contrast-induced nephropathy after percutaneous coronary intervention.

Authors:  Guoqiang Gu; Xuechao Yuan; Yaqing Zhou; Demin Liu; Wei Cui
Journal:  BMC Cardiovasc Disord       Date:  2019-06-24       Impact factor: 2.298

8.  Hydration Strategies for Preventing Contrast-Induced Acute Kidney Injury: A Systematic Review and Bayesian Network Meta-Analysis.

Authors:  Qiuping Cai; Ran Jing; Wanfen Zhang; Yushang Tang; Xiaoping Li; Tongqiang Liu
Journal:  J Interv Cardiol       Date:  2020-02-11       Impact factor: 2.279

9.  Relationship Between the Urine Flow Rate and Risk of Contrast-Induced Nephropathy After Emergent Percutaneous Coronary Intervention.

Authors:  Yong Liu; Lixia Lin; Yun Li; Hualong Li; Deng-Xuan Wu; Jian-Bin Zhao; Dan Lian; Yingling Zhou; Yuanhui Liu; Piao Ye; Peng Ran; Chongyang Duan; Shiqun Chen; Pingyan Chen; Ying Xian; Jiyan Chen; Ning Tan
Journal:  Medicine (Baltimore)       Date:  2015-12       Impact factor: 1.817

10.  Impact of low hemoglobin on the development of contrast-induced nephropathy: A retrospective cohort study.

Authors:  Jinzhong Xu; Meiling Zhang; Yinghua Ni; Jiana Shi; Ranran Gao; Fan Wang; Zhibing Dong; Lingjun Zhu; Yanlong Liu; Huimin Xu
Journal:  Exp Ther Med       Date:  2016-06-02       Impact factor: 2.447

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.